Lisata Therapeutics, Inc. files an 8-K: Material Modifications to Rights of Security Holders
Lisata Therapeutics filed an 8-K reporting material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws, plus other events. The filing's details are not in the headline or teaser, so the specific changes for shareholders are unclear.
From the filing
Item 3.03: Material Modifications to Rights of Security Holders; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Items listed in the filing. The full text is at SEC EDGAR.
Who is reporting it
- GlobeNewswirefirst at Nov 19, 2026, 9:09 AM ESTRead at GlobeNewswire (opens in a new tab)
- SEC EDGARfirst at Nov 19, 2026, 9:18 AM ESTRead at SEC EDGAR (opens in a new tab)
- Seeking Alphafirst at Nov 19, 2026, 10:27 AM ESTRead at Seeking Alpha (opens in a new tab)
Story so far
Reported by 3 sources
Lisata Therapeutics announced a one-for-fifteen reverse stock split of its common stock, with split-adjusted Nasdaq trading under the LSTA symbol starting at the November 23, 2026 open and a new CUSIP.
- Nov 19, 2026, 9:09 AM EST · GlobeNewswireConfirmedLisata Therapeutics, Inc. Announces Reverse Stock Split Effective November 23, 2026
- Nov 19, 2026, 9:18 AM EST · SEC EDGAR · this storyConfirmedLisata Therapeutics, Inc. files an 8-K: Material Modifications to Rights of Security Holders
- Nov 19, 2026, 10:27 AM EST · Seeking AlphaConfirmedLisata Therapeutics announces one-for-fifteen reverse stock split
- Nov 19, 2026, 5:10 PM EST · SEC EDGARConfirmedCo-Diagnostics, Inc. files an 8-K: Material Modifications to Rights of Security Holders
Comments
Log in or create a free account to comment.
No comments yet.
The headline links to the original source; the summary is written by The Market Standard. Nothing here is financial advice.